HUP0001719A3 - Microgranules containing cisplatin - Google Patents

Microgranules containing cisplatin

Info

Publication number
HUP0001719A3
HUP0001719A3 HU0001719A HUP0001719A HUP0001719A3 HU P0001719 A3 HUP0001719 A3 HU P0001719A3 HU 0001719 A HU0001719 A HU 0001719A HU P0001719 A HUP0001719 A HU P0001719A HU P0001719 A3 HUP0001719 A3 HU P0001719A3
Authority
HU
Hungary
Prior art keywords
containing cisplatin
microgranules containing
microgranules
cisplatin
Prior art date
Application number
HU0001719A
Other languages
English (en)
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of HUP0001719A2 publication Critical patent/HUP0001719A2/hu
Publication of HUP0001719A3 publication Critical patent/HUP0001719A3/hu
Publication of HU225425B1 publication Critical patent/HU225425B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0001719A 1997-02-11 1998-02-10 Microgranules containing cisplatin HU225425B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
PCT/FR1998/000251 WO1998034599A1 (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine

Publications (3)

Publication Number Publication Date
HUP0001719A2 HUP0001719A2 (hu) 2000-11-28
HUP0001719A3 true HUP0001719A3 (en) 2005-11-28
HU225425B1 HU225425B1 (en) 2006-11-28

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001719A HU225425B1 (en) 1997-02-11 1998-02-10 Microgranules containing cisplatin

Country Status (24)

Country Link
US (2) US6458389B1 (hu)
EP (1) EP0971702B1 (hu)
JP (1) JP4549445B2 (hu)
KR (1) KR100471672B1 (hu)
AR (1) AR011133A1 (hu)
AT (1) ATE255409T1 (hu)
BG (1) BG64247B1 (hu)
BR (1) BR9807319A (hu)
CA (1) CA2282082C (hu)
DE (1) DE69820239T2 (hu)
DK (1) DK0971702T3 (hu)
EA (1) EA001760B1 (hu)
ES (1) ES2210726T3 (hu)
FR (1) FR2759293B1 (hu)
HU (1) HU225425B1 (hu)
IL (1) IL131326A (hu)
IN (1) IN187998B (hu)
NO (1) NO323230B1 (hu)
NZ (1) NZ337216A (hu)
PL (1) PL191631B1 (hu)
PT (1) PT971702E (hu)
TW (1) TW561055B (hu)
WO (1) WO1998034599A1 (hu)
ZA (1) ZA981123B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
JP2002544220A (ja) * 1999-05-17 2002-12-24 デー．ベー．エフ． 植物物質を含有する顆粒及びその製造方法
EP1689373B1 (en) * 2003-10-10 2019-04-03 Ethypharm Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
DE602005007376D1 (de) * 2004-11-18 2008-07-17 Bristol Myers Squibb Co Magensaftresistent beschichtetes pellet mit ixabepilon
US20080069901A1 (en) * 2004-12-10 2008-03-20 Tmrc Co. , Ltd. Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
BRPI0722042B8 (pt) * 2007-09-21 2022-07-05 Evonik Roehm Gmbh composição farmacêutica de liberação controlada dependente do ph, e seu processo de preparação
MX2010003032A (es) * 2007-09-21 2010-04-09 Evonik R Hm Gmbh Composicion farmaceutica opioide de liberacion controlada ph dependiente con resistencia contra la influencia del etanol.
US20110070302A2 (en) * 2008-01-10 2011-03-24 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
KR101500792B1 (ko) * 2008-01-10 2015-03-09 에보니크 룀 게엠베하 결장에서 증가된 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
ES2848025T3 (es) 2012-09-04 2021-08-05 Eleison Pharmaceuticals LLC Prevención de la recidiva pulmonar del cáncer con cisplatino complejado con lípidos
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
WO2016169042A1 (en) * 2015-04-24 2016-10-27 Genedia Biotech Co. Ltd. Combination therapies for bladder cancer
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
EA201792512A1 (ru) 2015-06-12 2018-06-29 Вэксарт, Инк. Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
TWI795462B (zh) 2017-11-17 2023-03-11 日商鹽野義製藥股份有限公司 光安定性及溶出性優異的醫藥製劑
BR122022006356B1 (pt) * 2018-04-24 2022-10-04 Shionogi & Co., Ltd Forma de dosagem sólida
AR115354A1 (es) 2018-04-24 2020-12-23 Shionogi & Co Forma de dosis sólida con excelente estabilidad

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817B1 (fr) * 1981-03-11 1985-10-09 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム

Also Published As

Publication number Publication date
US6458389B1 (en) 2002-10-01
US20030017210A1 (en) 2003-01-23
IN187998B (hu) 2002-08-03
AU6626798A (en) 1998-08-26
BG64247B1 (bg) 2004-07-30
AR011133A1 (es) 2000-08-02
WO1998034599A1 (fr) 1998-08-13
IL131326A (en) 2005-03-20
CA2282082C (fr) 2005-10-18
FR2759293B1 (fr) 1999-04-30
KR20000070997A (ko) 2000-11-25
BG103647A (en) 2000-03-31
NO323230B1 (no) 2007-02-05
JP2001512433A (ja) 2001-08-21
EP0971702B1 (fr) 2003-12-03
HU225425B1 (en) 2006-11-28
FR2759293A1 (fr) 1998-08-14
NO993881L (no) 1999-09-29
DE69820239D1 (de) 2004-01-15
NO993881D0 (no) 1999-08-11
BR9807319A (pt) 2000-04-18
EP0971702A1 (fr) 2000-01-19
PT971702E (pt) 2004-04-30
KR100471672B1 (ko) 2005-03-07
ZA981123B (en) 1998-08-20
TW561055B (en) 2003-11-11
HUP0001719A2 (hu) 2000-11-28
PL335107A1 (en) 2000-04-10
NZ337216A (en) 2000-09-29
CA2282082A1 (fr) 1998-08-13
EA199900734A1 (ru) 2000-04-24
EA001760B1 (ru) 2001-08-27
ES2210726T3 (es) 2004-07-01
JP4549445B2 (ja) 2010-09-22
DE69820239T2 (de) 2004-10-07
DK0971702T3 (da) 2004-04-13
IL131326A0 (en) 2001-01-28
ATE255409T1 (de) 2003-12-15
PL191631B1 (pl) 2006-06-30
AU744001B2 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
IL131326A0 (en) Microgranules containing cisplatin
GB9711237D0 (en) Organomettallic Complexes
MX222768B (en) Organic-inorganic hybrid materials
TW506503U (en) Connectors
GB9819511D0 (en) Connector
GB2322175B (en) Connector
EP0969557A4 (en) INTERCONNECTS
EP0986840A4 (en) CONNECTOR
SG74046A1 (en) Connector
GB2332104B (en) Connector
GB9700521D0 (en) Connector
TW358592U (en) Eelctronic connector
GB9826593D0 (en) Connector
GB9704982D0 (en) Connector
GB9822585D0 (en) Connectors
TW335972U (en) Twin-antenna connector
GB2331875B (en) Connector
GB9713593D0 (en) Connectors
GB9713147D0 (en) Connector
AU744001C (en) Microgranules containing cisplatin
GB2324520B (en) Carrier
GB9709555D0 (en) Encapsulation
TW426249U (en) Anti-EMI connector
TW328856U (en) Attached terminals
GB9718383D0 (en) Carrier

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees